tiprankstipranks
Oruka Therapeutics, Inc. (ORKA)
:ORKA
US Market

Oruka Therapeutics (ORKA) Financial Statements

Compare
609 Followers

Oruka Therapeutics Financial Overview

Oruka Therapeutics's market cap is currently $468.01M. The company's EPS TTM is $-6.426; its P/E ratio is ―; Oruka Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -7.30M$ -10.60M$ -19.34M$ -9.77M$ -5.81M
EBITDA$ -5.42M$ -10.48M$ -19.24M$ -9.64M$ -5.55M
Net Income$ -5.34M$ -9.93M$ -19.32M$ -9.74M$ -5.48M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 37.86M$ 43.09M$ 54.92M$ 50.43M$ 8.54M
Total Debt$ 204.00K$ 280.00K$ 383.00K$ 409.00K$ 0.00
Net Debt$ -37.23M$ -42.16M$ -52.98M$ -48.66M$ -8.36M
Total Liabilities$ 841.00K$ 1.41M$ 3.88M$ 3.91M$ 926.00K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -5.01M$ -10.91M$ -18.80M$ -7.74M$ -4.80M
Operating Cash Flow$ -5.01M$ -10.91M$ -18.76M$ -7.72M$ -4.80M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Oruka Therapeutics Earnings and Revenue History

Oruka Therapeutics Debt to Assets

Oruka Therapeutics Cash Flow

Oruka Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis